Therefore, we investigated the impact of comorbidities, including diabetes mellitus and hypertension, on the study results but we found no difference in acylated and unacylated ghrelin levels between TA patients who have these comorbidities and those who do not. The gene discussed is GHRL; the disease is diabetes mellitus.